The catheter market is projected to register a CAGR of 8.3% during the forecast period, with a revenue of approximately USD 18,740 million in 2020 and expected to reach USD 30,200 million by 2026. The market is expected to observed good growth due to the increasing burden of cardiovascular, neurology, and urology disorders, increasing usage of minimally invasive procedures, and the rising demand for antimicrobial catheters.
With the rising COVID-19 pandemic across the world and the lockdown situation, it is expected to show a significant impact on the market due to on-hold services, such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19 disease. With the rising COVID-19, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies and the necessity to provide optimum care to the infected also widens. The increasing number of COVID-19 cases all around the world has thus helped in increasing the number of in-patient admissions.
As governments and healthcare institutions are found increasing and efficient medical treatment to treat COVID-19 patients, the usage of catheters will behold an upsurge in hospitals and emergency clinics. Patients with suspected or confirmed diagnosis of COVID-19 are being treated with catheters and hence the demand for these devices will remain huge throughout the pandemic. In April 2020, Bactiguard launches catheter for patients in need of continuous temperature monitoring that is a new urinary catheter.
The rising chronic disorders have thus become the most dominant cause of mortality and morbidity globally. According to the World Health Organization (2019), the number of deaths due to cardiovascular disease has increased by more than 2 million since 2000, to nearly 9 million worldwide. The alarming number of cardiac deaths has led to an increasing number of cardiac surgeries which has increased the usage of catheters in the market and thereby accelerated the market growth.
According to the Brain Aneurysm Foundation, globally, approximately 500,000 deaths are caused by brain aneurysms every year, and half of such individuals are aged 50 years or below. The annual rate of rupture is around 8-10 persons per 100,000 or about 30,000 people in the United States. Thus, with the increasing prevalence of neurovascular disorders, there is also a rising use of neurovascular catheter devices.
Furthermore, the growing demand for minimally invasive procedures is expected to increase the demand for catheters in the market. These procedures has increased the patient's preference for minimally invasive procedures, which is expected to favour the market growth. Hence with the increasing number of chronic surgeries being performed due to rising cases of chronic diseases, there is an increase in the demand for catheters that which will drive the market.
Key Market Trends
Urology Catheters Expected to be the Fastest Growing Segment in the Catheter Market
A urinary catheter is found to be necessary for a person facing difficulty passing urine naturally. The segment is expected to show high growth during the forecast period as these products are used for patients who suffer from urological disorders.
The rising cases of COVID-19 have resulted in significant disruptions globally and are expected to have a slight impact on the urinary catheters. Urinary catheters were being used for surgical applications and are expected to be impacted to some extent due to the temporary postponement of various elective surgeries, as authorities seek to ensure the availability of resources for COVID-19 patients. But due to the rising infection rate, there were still few launches that have helped in the stable market growth.
For instance, in April 2020, Bactiguard introduced a new urinary catheter, BIP Foley TempSensor for continuous temperature monitoring. The company announced that in the pandemic situation also they have a urinary catheter that combined with integrated temperature monitoring and infection control. Such technological advancements help the market to grow.
According to the study "Prevalence and associated factors of urinary incontinence in women living in China: a literature review" published in 2020, there are about 43-349 million Chinese women that have experienced urinary incontinence (UI). UI has a significant impact on women's physical and mental health and quality of life. The growing prevalence of urinary incontinence, an increasing number of surgical procedures are the major factors driving the growth of urinary catheters.
Moreover, favorable reimbursement policies and increasing urinary disorders are the key factors leading to enhanced demand for urinary catheters.
North America is Expected to Dominate the Market During the Forecast Period
The United States is expected to dominate the market due to the high government support for medical devices and an increasing number of surgeries. The other factors driving the market growth include the increasing prevalence of urological disorders, cardiovascular disorders, and the rising preference for minimally invasive procedures due to less operative time and few complications.
The rising COVID-19 has resulted in significant disruptions to business activities and is expected to have a short-term negative impact on the catheter market. The catheters used for surgeries are expected to impact to some extent due to the temporary postponement of non-emergent surgeries to ensure the availability of resources for COVID-19 patients that have impacted the market slightly.
According to the American Cancer Society, the estimated new cases of bladder cancer in Americans in 2020 were around 81,400, and about 17,980 deaths occurred due to it in the United States.
According to the study "Improving urinary catheterization practices in a rural hospital in Ontario" published in 2019, the overuse of urinary catheters has been a growing concern in the USA and Canadian healthcare systems that has impacted the overall sales in the market.
Furthermore, the rising geriatric population is one of the primary factors driving the market growth. As per the Population Reference Bureau's fact sheet, the number of Americans above 65 years of age is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share in the total population may rise from 16% to 23%, showing a positive impact on the market. The older population is often susceptible to chronic diseases, which is further expected to aid market growth.
Moreover, in 2018, Becton, Dickinson and Company (BD) have acquired TVA Medical, Inc. (US). This has strengthened company's portfolio with the addition of dialysis catheters, drug-coated balloons, standard angioplasty balloons, and endovascular stent graft products from TVA Medical. Hence the rapid increase in the patient pool in the United States tends to increase the demand for catheters that are increasing the overall growth of the market.
Competitive Landscape
There has been a wide number of companies that are increasing the focus of key players on developing the advanced catheters that will provide growth opportunities. These numerous manufacturers of the industry collaborate with major medical device distributors to market and supply their products globally or in certain countries. Various established business players are also adopting numerous organic and inorganic growth strategies to increase their market share. Also, the various product launches, mergers and acquisitions, and collaborations are the key strategies undertaken by these companies for sustainable growth.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Burden of Cardiovascular, Neurology, and Urology Disorders
- 4.2.2 Increasing Usage of Minimally Invasive Procedures
- 4.2.3 Rising Demand for the Antimicrobial Catheters
- 4.3 Market Restraints
- 4.3.1 Risks and Complications Associated with the Catheters
- 4.3.2 Presence of the Substitutes
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
- 5.1 By Product
- 5.1.1 Cardiovascular Catheters
- 5.1.2 Urology Catheters
- 5.1.3 Intravenous Catheters
- 5.1.4 Neurovascular Catheters
- 5.1.5 Others
- 5.2 By Distribution Channel
- 5.2.1 Hospital Stores
- 5.2.2 Retail Stores
- 5.2.3 Others
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States (By Product and By Distribution Channel)
- 5.3.1.2 Canada (By Product and By Distribution Channel)
- 5.3.1.3 Mexico (By Product and By Distribution Channel)
- 5.3.2 Europe
- 5.3.2.1 Germany (By Product and By Distribution Channel)
- 5.3.2.2 United Kingdom (By Product and By Distribution Channel)
- 5.3.2.3 France (By Product and By Distribution Channel)
- 5.3.2.4 Italy (By Product and By Distribution Channel)
- 5.3.2.5 Spain (By Product and By Distribution Channel)
- 5.3.2.6 Rest of Europe (By Product and By Distribution Channel)
- 5.3.3 Asia-Pacific
- 5.3.3.1 China (By Product and By Distribution Channel)
- 5.3.3.2 Japan (By Product and By Distribution Channel)
- 5.3.3.3 India (By Product and By Distribution Channel)
- 5.3.3.4 Australia (By Product and By Distribution Channel)
- 5.3.3.5 South Korea (By Product and By Distribution Channel)
- 5.3.3.6 Rest of Asia-Pacific (By Product and By Distribution Channel)
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC (By Product and By Distribution Channel)
- 5.3.4.2 South Africa (By Product and By Distribution Channel)
- 5.3.4.3 Rest of Middle East and Africa (By Product and By Distribution Channel)
- 5.3.5 South America
- 5.3.5.1 Brazil (By Product and By Distribution Channel)
- 5.3.5.2 Argentina (By Product and By Distribution Channel)
- 5.3.5.3 Rest of South America (By Product and By Distribution Channel)
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 B. Braun Melsungen AG
- 6.1.2 Coloplast
- 6.1.3 C.R. Bard (Becton, Dickinson and Company)
- 6.1.4 Hollister Incorporated
- 6.1.5 Medtronic Plc
- 6.1.6 Teleflex
- 6.1.7 Boston Scientific Corporation
- 6.1.8 Biotronik
- 6.1.9 Abbott Laboratories
- 6.1.10 Smiths Medical, Inc.
- 6.1.11 Edwards Lifesciences Corporation
- 6.1.12 DePuy Synthes (Johnson & Johnson)
- 6.1.13 Terumo Corporation
- 6.1.14 Stryker Corporation
- 6.1.15 Integer Holdings Corporation
- 6.1.16 ICU Medical Inc.
- 6.1.17 Teleflex Incorporated
- 6.1.18 ConvaTec Group
- 6.1.19 Cook Medical
- 6.1.20 Merit Medical Systems
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
